Who has invested in Neurogene?

Samsara BioCapital, EcorR1 Capital, Cormorant Asset Management, Redmile Group are named among the investors backing Neurogene.

Neurogene Funding: $69M Raised, Series A (2019)

Neurogene funding overview

Neurogene has raised $69M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2019. The round record for Neurogene runs through 2019; nothing later has been disclosed. Investors on record include Samsara BioCapital, EcorR1 Capital, Cormorant Asset Management, Redmile Group. 4 distinct backers are named across the disclosed rounds.

Neurogene at a glance

Total raised: $69M
Latest round: Series A
Latest round date: February 2019
Notable investors: Samsara BioCapital, EcorR1 Capital, Cormorant Asset Management, Redmile Group

Frequently asked about Neurogene funding

How much has Neurogene raised?: Neurogene has raised $69M in total disclosed funding across the rounds on record.
Who has invested in Neurogene?: Samsara BioCapital, EcorR1 Capital, Cormorant Asset Management, Redmile Group are named among the investors backing Neurogene.
What was the latest Neurogene funding round?: The most recent disclosed round is a Series A, announced in February 2019.
Where is Neurogene based?: No headquarters location is disclosed for Neurogene.
When did Neurogene last raise?: The last disclosed Neurogene round closed in February 2019 at Series A.

We update the Neurogene record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies and their backers are listed below.

Neurogene Funding: $69M Raised, Series A (2019)

Neurogene funding overview

Neurogene at a glance

Frequently asked about Neurogene funding

Companies related to Neurogene (18)

Browse related funding lists (5)